[MO32] Mini-Oral Session 32　Clinical Trial Facilitation Program 2
【E】

[MO32-6] Patient satisfaction surveys for cancer genomic medicine, initiating at core hospitals in Japan

^○Katsutoshi Oda¹, Hidenori Kage¹, Manabu Muto², Tsuchihara Katsuya³, Okita Natsuko⁴, Okuma Yusuki⁵, Kikuchi Junko⁶, Hidekazu Shirota⁷, Hayashi Hideyuki⁸, Toshio Kokuryo⁹, Sakai Daisuke¹⁰, Mariko Kochi¹¹, Makoto Kubo¹², Hirotsugu Kenmotsu¹³, Ushiku Aya^1,14, Masahiko Tanabe^1,15, Tetsuo Ushiku^1,14, Kiyoshi Miyagawa^1,16, Yasuyuki Seto¹⁷ (1.Department of Clinical Genomics, The University of Tokyo Hospital, 2.Department of Therapeutic Oncology, Kyoto University, 3.Division of Translational Informatics, National Cancer Center Hospital East, 4.Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5.Department of Thoracic Oncology, National Cancer Center Hospital, 6.Internal Medicine I, Hokkaido University, 7.Department of Clinical Oncology, Tohoku University Hospital, 8.Genomics Unit, Keio Cancer Center, Keio University, 9.Division of Surgical Oncology, Department of Surgery, Nagoya University, 10.Center for Cancer Genomics and Personalized Medicine, Osaka University, 11.Department of Clinical Genetics and Genomic Medicine, Okayama University, 12.Department of Surgery and Oncology, Kyushu University, 13.Division of Thoracic Oncology, Shizuoka Cancer Center, 14.Department of Pathology, The University of Tokyo, 15.Department of Breast and Endocrine Surgery, The University of Tokyo, 16.Center for Disease Biology and Integrative Medicine, The University of Tokyo, 17.Gastrointestinal Surgery, The University of Tokyo)